Trial
NCT04398368
Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Mayo Clinic
Collaborators
—
Condition
Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
Intervention
Gemcitabine Hydrochloride
Why stopped
Focus research efforts on other projects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-08